Can gut-restricted PDE4 inhibitors transform treatment for ulcerative colitis and Crohn’s?
Palisade Bio’s PALI-2108 secures a Japanese patent. Explore how this gut-targeted PDE4 inhibitor could change the game in ulcerative colitis and Crohn’s.
Pharma & Biotech